NeoCura
新合生物
NeoCura
Biotech/Healthcare
Xinhe Biotechnology's pipeline mainly includes tumor neoantigen vaccines, tumor microenvironment immunomodulators, and viral vaccines. NeoCura Ag, a tumor neoantigen vaccine, is a cutting-edge treatment combining AI technology.
Latest round: Series A (2020)
Source: ChinaBulls — chinabulls.com
Last updated 2020-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.